SynthesisCNS neuroscience & therapeutics2022

Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis.

Amir Valizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.